Detalles de la búsqueda
1.
An adaptive randomized clinical trial in interstitial cystitis/bladder pain syndrome evaluating efficacy of ASP3652 and the relationship between disease characteristics and Hunner's lesions.
World J Urol
; 39(6): 2065-2071, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32734461
2.
Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis.
Lancet Oncol
; 19(3): 310-322, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29449192
3.
Signs and symptoms that distinguish detrusor underactivity from mixed detrusor underactivity and bladder outlet obstruction in male patients.
Neurourol Urodyn
; 37(4): 1501-1505, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29356059
4.
What are the additional signs and symptoms in patients with detrusor underactivity and coexisting detrusor overactivity?
Neurourol Urodyn
; 37(7): 2220-2225, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29635760
5.
Improvement in hematological, visceral, and skeletal manifestations of Gaucher disease type 1 with oral eliglustat tartrate (Genz-112638) treatment: 2-year results of a phase 2 study.
Blood
; 116(20): 4095-8, 2010 Nov 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-20713962
6.
A phase 2 study of eliglustat tartrate (Genz-112638), an oral substrate reduction therapy for Gaucher disease type 1.
Blood
; 116(6): 893-9, 2010 Aug 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-20439622
7.
Three-year pooled analysis of factors associated with clinical outcomes across dabrafenib and trametinib combination therapy phase 3 randomised trials.
Eur J Cancer
; 82: 45-55, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28648698
8.
Signs and Symptoms of Detrusor Underactivity: An Analysis of Clinical Presentation and Urodynamic Tests From a Large Group of Patients Undergoing Pressure Flow Studies.
Eur Urol
; 69(2): 361-9, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26318706
9.
The efficacy and safety of mirabegron compared with solifenacin in overactive bladder patients dissatisfied with previous antimuscarinic treatment due to lack of efficacy: results of a noninferiority, randomized, phase IIIb trial.
Ther Adv Urol
; 7(4): 167-79, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26445596
10.
Efficacy of the ß3-adrenoceptor agonist mirabegron for the treatment of overactive bladder by severity of incontinence at baseline: a post hoc analysis of pooled data from three randomised phase 3 trials.
Eur Urol
; 67(1): 11-14, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25092537
Resultados
1 -
10
de 10
1
Próxima >
>>